About Lagniappe- RxLPS
Lagniappe- RxLPS is a Healthcare company based in Fort Worth (United States) founded in 2011, and was acquired by Rx30 Pharmacy Software in May 2016. Pharmacy management systems, point-of-sale solutions, and value-added services are provided. Lagniappe- RxLPS has raised $9.54 million across 1 funding round from investors including Rx30 Pharmacy Software. The company has 198 employees. Lagniappe- RxLPS has completed 1 acquisition, including OPUS-ISM. Lagniappe- RxLPS offers products and services including Pharmacy Software, Pharmacy Point-of-Sale, Patient Management, Patient Communication, and Support Services. Its focus areas include HealthTech, Pharmacy IT and Pharmacy Management Systems. Its legal entity is LAGNIAPPE HEALTH ACQUISITION COMPANY, INC. Its competitors include OmniSYS, Xevant and Scripta Insights; 3 of its 3 listed competitors have raised funding.
Company details
Founded in 2011 and based in Fort Worth, United States, Lagniappe RxLPS operates in the pharmacy software sector. Windows-based RX-1 Pharmacy Software System is offered, featuring touchscreen-driven tools for prescription filling. Integration with touchPOS, a point-of-sale product, enables direct posting of accounts receivable to pharmacy files and tracks prescription statuses such as sold, available, or pending. Value-added services support overall pharmacy operations.
- Headquarters Fort Worth, United States
- Employees 198
- Stage Acquired
- SectorsHealthcare
- Email••••••••
- Website rxlps.com
- Social LinkedIn X Facebook
- Acquired by Rx30 Pharmacy Software (May 2016)
- Legal Name Lagniappe Health Acquisition Company, Inc.
- Total Equity Funding$9.54M (USD)
in 1 rounds
- Latest Funding Round$9.54M (USD), Series A
Sep 2014
- Investors
- Employee Count198
- Investments & Acquisitions
- Acquired byRx30 Pharmacy Software
(May 2016)
Products & Services of Lagniappe- RxLPS
Lagniappe- RxLPS offers a comprehensive portfolio of products and services, including Pharmacy Software, Pharmacy Point-of-Sale, Patient Management, Patient Communication, and Support Services.
Software for pharmacy operations and inventory management
System for handling sales and transactions in pharmacies
Tools for managing patient records and interactions
Software for patient engagement and messaging
Services for technical assistance and system maintenance
Funding Insights of Lagniappe- RxLPS
Lagniappe- RxLPS has successfully raised a total of $9.54M through 1 strategic funding round. The most recent funding activity was a Series A round of $9.54 million completed in September 2014. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding $9.54M
- Total Rounds 1
- Last Round Series A — $9.54M
- First Round $9.54M
(Sep 2014)
All 1 funding rounds of Lagniappe- RxLPS with amounts and investors; the two latest post-money valuations are shown, the rest are part of the premium plan.
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Sep 2014 | $9.54M | Series A | – | – | – |
1 investors in total: 1 institutional.
Investors in Lagniappe- RxLPS
Lagniappe- RxLPS has secured backing from 1 investor. Prominent investors backing the company include Rx30 Pharmacy Software.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
Pharmacy management software and integrated solutions are provided. | 1977 | rx30.com | Orlando, United States |
Investor details for Lagniappe- RxLPS
The complete investor list, round-by-round participation and investor portfolios require an active premium plan.
- Complete investor list
- Round participation
- Investor portfolios
- Co-investor network
Verified entity values are shown only after access is granted.
People of Lagniappe- RxLPS
1 people are tracked at Lagniappe- RxLPS (1 in leadership); the tracked headcount is 198.
| Name | Role | Group |
|---|---|---|
Eric Peters | CEO | Leadership |
Complete people profiles for Lagniappe- RxLPS
Full employee and board profiles, team structure, tenure and professional contact details require an active premium plan.
- Full employee list
- Team structure
- Board tenure
- Professional contacts
Verified entity values are shown only after access is granted.
Investments & Acquisitions by Lagniappe- RxLPS
Lagniappe- RxLPS has strategically engaged in corporate development activities, having acquired 1 company. Notable acquisitions include OPUS-ISM.
| Company Name | Description | Domain | Location | Founded | Acquired | Amount |
|---|---|---|---|---|---|---|
Limited information is available on core activities. | opus-ism.com | Texas, United States | 2004 | Sep 2012 | •••• |
Complete acquisition details for Lagniappe- RxLPS
Acquired stakes, deal sources and the complete acquisition history require an active premium plan.
- Acquired stakes
- Deal sources
- Complete history
- Exports
Verified entity values are shown only after access is granted.
Timeline of Lagniappe- RxLPS
4 dated milestones of Lagniappe- RxLPS across 5 years, from founding to its latest funding, stage changes and deals.
- Founded Lagniappe- RxLPS is founded.
- Acquisition Acquires OPUS-ISM.
- Funding First funding round of $9.5M.
- Exit Acquired by Rx30 Pharmacy Software.
Competitors of Lagniappe- RxLPS
Lagniappe- RxLPS has 3 listed competitors in our database, 3 of them funded. They include OmniSYS, Xevant and Scripta Insights.
| Company Name | Domain | Founded | HQ Location | Total funding | Employees | Description |
|---|---|---|---|---|---|---|
| omnisys.com | 1997 | Dallas, United States | $11M | 151 | Offers medical billing services for pharmacies and manages business policies and relationships. | |
| xevant.com | 2017 | Draper, United States | $17.18M | 42 | A SaaS-based platform for pharmacy benefit management is provided. | |
| scriptainsights.com | 2019 | Wellesley, United States | $17M | AI-driven pharmacy benefit management software is provided for pharmacies. |
Detailed competitors of Lagniappe- RxLPS
The full competitor set, operating metrics and side-by-side benchmarks require an active premium plan.
- Full competitor set
- Operating metrics
- Benchmarks
- Competitive positioning
Verified entity values are shown only after access is granted.
Top companies in Pharmacy & Healthcare Retail Systems
3 companies that operate in the same segment as Lagniappe- RxLPS (Pharmacy & Healthcare Retail Systems) in United States, ranked by their profile score on The Company Check.
| Company | Description | Founded | Location | Total funding | Revenue | Employees |
|---|---|---|---|---|---|---|
Alto Pharmacy is focused on providing convenient prescription delivery services. | 2015 | San Francisco, California, United States | USD 591.64 M | 802 | ||
Optum is recognized as a leading health solution and care delivery organization. | 2011 | Eden Prairie, Minnesota, United States | USD 250 K | USD 383.36 M | 140 | |
Materials management and business analytics solutions for healthcare are provided. | 1992 | Mountain View, California, United States | USD 20 M | USD 1.18 B | 3,670 |
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Frequently Asked Questions about Lagniappe- RxLPS
Lagniappe- RxLPS was founded in 2011 and raised its 1st funding round 3 years after it was founded.
Lagniappe- RxLPS is headquartered in Fort Worth, United States. It is registered at Fort Worth, Texas, United States.
Lagniappe- RxLPS is a funded company, having raised a total of $9.54M across 1 funding round to date. The company's 1st funding round was a Series A of $9.54M, raised on Sep 2014.
Lagniappe- RxLPS has 198 employees.
Founded in 2011 and based in Fort Worth, United States, Lagniappe RxLPS operates in the pharmacy software sector. Windows-based RX-1 Pharmacy Software System is offered, featuring touchscreen-driven tools for prescription filling. Integration with touchPOS, a point-of-sale product, enables direct posting of accounts receivable to pharmacy files and tracks prescription statuses such as sold, available, or pending. Value-added services support overall pharmacy operations.
Lagniappe- RxLPS's top competitors include Scripta Insights, Xevant and OmniSYS.
Lagniappe- RxLPS offers Pharmacy Software, Pharmacy Point-of-Sale, Patient Management, Patient Communication, and Support Services.
Lagniappe- RxLPS has made 1 acquisition, including OPUS-ISM.
Lagniappe- RxLPS has 1 investor. Key investors include Rx30 Pharmacy Software.
Lagniappe- RxLPS operates through Lagniappe Health Acquisition Company, Inc..
Yes. Lagniappe- RxLPS was acquired by Rx30 Pharmacy Software in May 2016.